Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumors
SAN DIEGO — Use of neoadjuvant axitinib (Inlyta) resulted in significant reductions in tumor size and complexity, enabling partial nephrectomy in a cohort of patients with highly complex renal masses in whom the procedure would ordinarily not be feasible, according to an interim analysis from a small phase II trial. A course of the tyrosine […]